CYTEK BIOSCIENCES, INC. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a3aeed89-dcf2-4089-bfa1-a6a218facc60/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-40.4M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-012352 |
| FY 2024 | $-20.5M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-008780 |
| FY 2023 | $-27.8M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-010933 |
| FY 2022 | $-1.8M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005610 |
| FY 2021 | $9.2M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004106 |
| FY 2020 | $13.7M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-004106 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).